COVID-19: CRS4 massive sequencing facility available for studies on SARS-CoV-2

The CRS4 (Center for Advanced Studies, Research and Development in Sardinia) opens to international collaboration with partners who want to test the use of genomic sequencing, bioinformatics and data analysis technologies. The machines of the NEXT massive sequencing facility located in the Technology Park of Pula (Cagliari), will be made available to researchers from all over the world who will have the opportunity to request access remotely with a priority procedure - i.e. without having to physically move to the Pula laboratories - to carry out experiments useful for studying and developing new diagnostic methodologies, new therapies, carrying out sequence studies to support the development of vaccines, identifying the best treatments for the treatment of the disease, supporting epidemiological monitoring useful for modulating the impact of public health interventions, using massive sequencing technologies on samples of non-pathogenic nucleic acids.

The call is highlighted in the homepage of the NEXT massive sequencing facility

For further information: Giorgio Fotia, CRS4, Director of Biosciences and NEXT Platform. 


Questo sito utilizza cookie tecnici e assimilati. Possono essere presenti anche cookie profilazione di terze parti. Se vuoi saperne di più o negare il consenso a tutti o ad alcuni cookie leggi l'informativa completa. Proseguendo nella navigazione (anche con il semplice scrolling) acconsenti all'uso dei cookie. This site uses technical and anonymized analytics cookies only. There may also be profiling third-party cookies. Please read the cookie information page to learn more about how we use cookies or blocking them. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.